News

An interdisciplinary team from the University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year. These findings are detailed in the new edition of Nature.

When a whole country's public health is at stake, making the wrong policy choices can cost lives and money. That's why researchers have worked to develop computer simulations of epidemics that can model individual behaviors and interactions to predict the spread of disease and the efficacy of interventions.

Consumers are one step closer to benefiting from packaging that could give simple text warnings when food is contaminated with deadly pathogens like E. coli and Salmonella, and patients could soon receive real-time diagnoses of infections such as C. difficile right in their doctors’ offices, saving critical time and trips to the lab. Researchers at McMaster University have developed a new way to print paper biosensors, simplifying the diagnosis of many bacterial and respiratory infections.

Teamwork and a multi-modal approach to infection prevention and control were the driving forces behind positive change and improved patient outcomes at several institutions that were honored in late 2014 by the Fine Foundation and the Jewish Healthcare Foundation (JHF). The Fine Awards for Teamwork Excellence in Health Care recognized frontline workers in the greater Pittsburgh, Pa. area who elevate and disseminate best practices in infection control - a quality measure that influences whether providers receive incentive payments or incur penalties from the Centers for Medicare and Medicaid Services (CMS).